bioAffinity Technologies Files S-1 for Public Offering

Ticker: BIAFW · Form: S-1 · Filed: Apr 11, 2025 · CIK: 1712762

Sentiment: neutral

Topics: ipo, registration-statement, biotech

TL;DR

bioAffinity Tech just filed an S-1, looks like they're going public. Watch this space.

AI Summary

bioAffinity Technologies, Inc. filed an S-1 form on April 11, 2025, indicating a public offering. The company, based in San Antonio, TX, is involved in commercial physical and biological research. Financial details regarding the offering size or specific use of proceeds are not yet detailed in this initial filing.

Why It Matters

This S-1 filing signals bioAffinity Technologies' intention to raise capital through the public markets, which could fund further research and development or expansion of its commercial activities.

Risk Assessment

Risk Level: medium — As a research-focused company filing an S-1, the specific financial details and market reception are still unknown, introducing inherent investment risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this S-1 filing?

The S-1 filing indicates bioAffinity Technologies, Inc.'s intention to register securities for a public offering.

Where is bioAffinity Technologies, Inc. located?

The company's business and mailing address is 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX 78217.

When was this S-1 form filed?

This S-1 form was filed on April 11, 2025.

What industry does bioAffinity Technologies, Inc. operate in?

The company is classified under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731].

What is the SEC File Number associated with this filing?

The SEC File Number for this filing is 333-286497.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on April 11, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing